Trial Profile
Zonisamide and Methylprednisolone to Prevent Noise-induced Temporary Hearing Loss
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase I/II
Latest Information Update: 09 Nov 2017
Price :
$35
*
At a glance
- Drugs Methylprednisolone (Primary) ; Zonisamide (Primary)
- Indications Noise-induced hearing loss
- Focus Therapeutic Use
- 02 Nov 2017 Planned End Date changed from 1 Jan 2020 to 1 Nov 2017.
- 02 Nov 2017 Planned primary completion date changed from 1 Dec 2019 to 1 Nov 2017.
- 02 Nov 2017 Planned initiation date changed from 1 Jun 2017 to 31 Oct 2017.